Veradigm Inc.
Veradigm Inc. (MDRX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mdrx · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Veradigm Inc. (MDRX) measures how much investors pay for each dollar of the company's trailing earnings. MDRX's current PE ratio of N/A is calculated by dividing its stock price of $4.58 by its TTM earnings per share of -$0.67.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2003 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 11 fiscal years · Front-end computedMinQ1 · 25%48.7x
MedianQ3 · 75%133.8x
Max
At N/A, MDRX's current P/E is lower than in 0% of its annual fiscal year readings over the past 11 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Veradigm Inc.You MDRX | $777M | N/A | — | -$0.67 |
 Arjo AB (publ) ARRJF | $891M | 25.18x | +6.7% | $1.23 |
 EL.En. S.p.A. ELEAF | $760M | 19.67x | -16.7% | $0.54 |
 Valneva SE INRLF | $520M | N/A | — | -$0.68 |
 LifeTech Scientific Corporation LFTSF | $858M | 33.56x | +42.2% | $0.05 |
 Panamera Holdings Corporation PHCI | $188M | N/A | — | -$0.01 |
 Safilo Group S.p.A. SAFLF | $907M | 16.01x | -32.2% | $0.12 |
Industry Average 4 peers with valid PE | — | 23.61x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-0.67 | — | |
2021-12-31 FY2021 | 19.03x | $0.97 | +479.7% | |
2020-12-31 FY2020 | 3.28x | $4.40 | — | |
2019-12-31 FY2019 | — | $-1.10 | — | |
2018-12-31 FY2018 | 4.66x | $2.07 | — | |
2017-12-31 FY2017 | — | $-1.09 | — | |
2016-12-31 FY2016 | — | $-0.14 | — | |
2015-12-31 FY2015 | — | $-0.01 | — | |
2014-12-31 FY2014 | — | $-0.37 | — | |
2013-12-31 FY2013 | — | $-0.59 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Veradigm Inc. (MDRX) measures how much investors pay for each dollar of the company's trailing earnings. MDRX's current PE ratio of N/A is calculated by dividing its stock price of $4.58 by its TTM earnings per share of -$0.67.
Frequently asked questions
MDRX pe ratio · 6 questionsMDRX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.58 and TTM EPS of -$0.67. Data sourced from Financial Modeling Prep via MDRX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Veradigm Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09